行情

BIO

BIO

Bio Rad实验室
NYSE

实时行情|Nasdaq Last Sale

788.35
+3.13
+0.40%
盘后: 788.35 0 0.00% 16:23 09/17 EDT
开盘
786.15
昨收
785.22
最高
794.48
最低
780.64
成交量
33.50万
成交额
--
52周最高
832.70
52周最低
490.73
市值
234.71亿
市盈率(TTM)
5.88
分时
5日
1月
3月
1年
5年
马里奥·加贝利 (Mario Gabelli) 认为要购买的 10 只医疗保健股票
In this article, we discuss the 10 healthcare stocks to buy according to Mario Gabelli. If you want to skip our detailed analysis of these stocks, go directly to the 5 Healthcare Stocks to Buy According to Mario Gabelli. Veteran investor Mario Gabelli is n...
Insider Monkey · 1天前
2029 年全球色谱仪器市场行业分析、规模、份额、增长、趋势和预测
Research Nester published a report titled which delivers detailed overview of the global chromatography instrumentation market in terms of market segmentation by systems, consumables, application, and by region.
AmericaNewsHour · 2天前
面向增长型投资者的三只股票
GuruFocus News · 3天前
Bio-Rad (BIO) 升级为强力买入:这就是原因
Bio-Rad (BIO) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks · 3天前
易感性生物标志物市场-预期增长及其因素、复合年增长率、行业规模、业务前景和 2030 年预测
Research Nester published a report titled which delivers detailed overview of the global predisposition biomarkers market in terms of market segmentation by type, application, end-user, and by region.
AmericaNewsHour · 3天前
单细胞基因组测序市场:产品规格、份额、规模、新兴趋势、竞争分析和 2028 年预测
Research Nester published a report titled which delivers detailed overview of the global single cell genome sequencingmarket in terms of market segmentation by product, application, end user and by region.
AmericaNewsHour · 4天前
核酸分离和纯化市场:产品规格、份额、规模、新兴趋势、竞争分析和 2028 年预测
Research Nester published a report titled which delivers detailed overview of the global nucleic acid isolation and purification market in terms of market segmentation by type, product, method, application, end-user and by region.
AmericaNewsHour · 4天前
Bio-Rad Laboratories (BIO) 一周内上涨 0.05%:您应该知道的
Zacks.com · 5天前
更多
财务预测
实际值(美元)
预测值(美元)
利润表更多
净利润(美元)
同比(%)
资产负债表更多
总资产(美元)
总负债(美元)
资产负债率(%)
现金流表更多
经营现金流(美元)
同比(%)
了解BIO最新的财务预测,通过BIO每股收益,每股净资产,每股现金流等数据分析Bio Rad实验室近期的经营情况,然后做出明智的投资选择。
分析师评级

4位分析师的综合评级

强力推荐

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测
分析师预测BIO价格均价为856.25,最高价位930.00,最低价为795.00。
EPS
机构持股
总机构数: 661
机构持股: 2,083.98万
持股比例: 70.00%
总股本: 2,977.26万
类型机构数股数
增持
189
126.14万
建仓
58
26.79万
减持
165
142.00万
平仓
41
30.54万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
医疗设备、用品及经销
-0.10%
医疗设备和用品
+0.65%
高管信息
Chairman/President/Chief Executive Officer/Director
Norman Schwartz
Chief Financial Officer/Executive Vice President
Ilan Daskal
Chief Operating Officer/Executive Vice President
Andrew Last
Executive Vice President/General Counsel/Secretary
Timothy Ernst
Executive Vice President
Michael Crowley
Executive Vice President
Giovanni Magni
Executive Vice President
Annette Tumolo
Executive Vice President
Dara Wright
Vice President/Treasurer
Ronald Hutton
Lead Director/Independent Director
Gregory Hinckley
Director
Alice Schwartz
Independent Director
Jeffrey Edwards
Independent Director
Melinda Litherland
Independent Director
Arnold Pinkston
暂无数据
BIO 简况
Bio-Rad Laboratories, Inc.是一家制造商和经销商。该公司生产和供应生命科学研究、医疗保健、分析化学以及用于分离化学和生物材料及识别、分析和净化其成分等其他市场的产品与系统。该公司通过两个业务部门运营:生命科学部门和临床诊断部门。生命科学部门开发、制造及销售6000种用于研究技术、生物制药生产过程和食品测试制度的试剂、仪器和实验室仪器。临床诊断部门为全球诊断市场设计、制造、销售和支持服务于临床试验的测试系统、信息系统、测试套件和专门的质量控制器。

微牛提供Bio-Rad Laboratories, Inc.(NYSE-BIO)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的BIO股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易BIO股票基本功能。